Catalyst Funds Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,200
Closed -$58.1K 1446
2024
Q2
$58.1K Buy
+2,200
New +$58.1K 0.02% 390